Daclizumab Subcutaneous and Loteprednol
Determining the interaction of Daclizumab Subcutaneous and Loteprednol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: loteprednol ophthalmic
Brand name: Alrex, Inveltys, Lotemax, Lotemax SM
Synonyms: Loteprednol (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Loteprednol and Tobramycin
- Daclizumab Subcutaneous-Loteprednol and tobramycin ophthalmic
- Daclizumab Subcutaneous-Loteprednol Etabonate
- Daclizumab Subcutaneous-Loteprednol Eye Drops
- Daclizumab Subcutaneous-Loteprednol Eye Drops 0.2%
- Daclizumab Subcutaneous-Loteprednol Eye Drops 0.5% and 1%
- Loteprednol-Dacogen
- Loteprednol-Dacomitinib
- Loteprednol-Dactinomycin
- Loteprednol-Dactinomycin Injection
- Loteprednol-Dactinomycin Intravenous
- Loteprednol-Daklinza